The Omicron variant of concern: Diversification and convergent evolution in spike protein, and escape from anti-Spike monoclonal antibodies.

Focosi, Daniele; McConnell, Scott; Casadevall, Arturo

Focosi, Daniele; McConnell, Scott; Casadevall, Arturo.

Affiliation

Focosi D; North-Western Tuscany Blood Bank, Pisa University Hospital, Pisa, Italy. Electronic address: daniele.focosi@gmail.com.
McConnell S; Department of Medicine, Johns Hopkins School of Public Health and School of Medicine, Baltimore, MD, USA.
Casadevall A; Department of Medicine, Johns Hopkins School of Public Health and School of Medicine, Baltimore, MD, USA.

Drug Resist Updat ; 65: 100882, 2022 12.

Article in En | MEDLINE | ID: mdl-36260961

Subject(s)

Antineoplastic Agents, Immunological; COVID-19; Humans; Antibodies, Monoclonal/genetics; Antibodies, Monoclonal/therapeutic use; SARS-CoV-2/genetics; Spike Glycoprotein, Coronavirus/genetics; Antibodies, Viral; Antibodies, Neutralizing; COVID-19 Serotherapy

Key words

B.1.1.529; BA.1; BA.2; BA.2.12.1; BA.2.75; BA.4; BA.4.6; BA.5; Omicron; SARS-CoV-2; Spike; VOC; Variant of concern

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Agents, Immunological / COVID-19 Limits: Humans Language: En Journal: Drug Resist Updat Journal subject: ANTINEOPLASICOS Year: 2022 Document type: Article Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google